azathioprine has been researched along with Diffuse Parenchymal Lung Disease in 81 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The objective of this study was to evaluate the effect of AZA and MMF on lung function and prednisone dose in myositis-related ILD (M-ILD)." | 7.91 | Long-Term Treatment With Azathioprine and Mycophenolate Mofetil for Myositis-Related Interstitial Lung Disease. ( Albayda, J; Casal-Dominguez, M; Christopher-Stine, L; Danoff, SK; Huapaya, JA; Johnson, C; Mammen, AL; Paik, JJ; Pinal-Fernandez, I; Sanyal, A; Silhan, L, 2019) |
| " We report the successful use of oral cyclophosphamide, followed by azathioprine maintenance, in the treatment of a patient with dermatomyositis-related rapidly deteriorating ILD, resistant to steroid." | 7.72 | Successful treatment of dermatomyositis-related rapidly progressive interstitial pneumonitis with sequential oral cyclophosphamide and azathioprine. ( Mok, CC; Szeto, ML; To, CH, 2003) |
| "The clinical features of ASS include interstitial lung disease (ILD), myositis, arthritis, Raynaud's phenomenon, mechanic's hands, and unexplained fever." | 5.72 | A 25-Year-Old Saudi Woman with a 2-Year History of Antisynthetase Syndrome with Interstitial Lung Disease Who Commenced Azathioprine Treatment in the Third Trimester of Pregnancy and Had a Successful Birth at Term. ( Alshwairikh, LA; Babay, Z, 2022) |
| " The objective of this study was to evaluate the effect of AZA and MMF on lung function and prednisone dose in myositis-related ILD (M-ILD)." | 3.91 | Long-Term Treatment With Azathioprine and Mycophenolate Mofetil for Myositis-Related Interstitial Lung Disease. ( Albayda, J; Casal-Dominguez, M; Christopher-Stine, L; Danoff, SK; Huapaya, JA; Johnson, C; Mammen, AL; Paik, JJ; Pinal-Fernandez, I; Sanyal, A; Silhan, L, 2019) |
| "We identified all patients treated for PM/DM-ILD and assessed cyclophosphamide (CYC), azathioprine (AZA) and mycophenolate (MMF) when used as first-line steroid sparing therapy for effects on pulmonary function variables, dyspnea and tolerance at six and twelve months." | 3.79 | A retrospective review of clinical features and treatment outcomes in steroid-resistant interstitial lung disease from polymyositis/dermatomyositis. ( Arrossi, V; Chapman, JT; Culver, DA; Mira-Avendano, IC; Parambil, JG; Xu, M; Yadav, R, 2013) |
| " In univariate analysis, older age at PM/DM onset, anemia, thrombocytopenia, leukopenia, diabetes mellitus, ILD, cancer, and non-use of azathioprine were associated with higher mortality (p = 0." | 3.77 | Survival analysis of patients with dermatomyositis and polymyositis: analysis of 192 Chinese cases. ( Chang, HC; Chen, IJ; Ho, HH; Kuo, CF; Luo, SF; See, LC; Shen, YM; Wu, YJ; Yu, KH, 2011) |
| " We report the successful use of oral cyclophosphamide, followed by azathioprine maintenance, in the treatment of a patient with dermatomyositis-related rapidly deteriorating ILD, resistant to steroid." | 3.72 | Successful treatment of dermatomyositis-related rapidly progressive interstitial pneumonitis with sequential oral cyclophosphamide and azathioprine. ( Mok, CC; Szeto, ML; To, CH, 2003) |
| " Patients were treated with azathioprine and low-dose prednisone if they had progressive pulmonary symptoms (deterioration in the dyspnea score) or poor or deteriorating lung function." | 3.72 | Experience with azathioprine in systemic sclerosis associated with interstitial lung disease. ( Cassim, B; Dheda, K; Lalloo, UG; Mody, GM, 2004) |
| "A 47-year-old man with dermatomyositis and interstitial pneumonia had been treated with prednisolone since May, 1992, and with azathioprine since April, 1993." | 3.69 | [Primary pulmonary non-Hodgkin's lymphoma in a patient with dermatomyositis]. ( Arima, N; Kawamata, N; Kohyama, T; Mori, H; Tanaka, H; Terashi, K; Yamada, H; Yamaguchi, A, 1997) |
| "Rheumatoid arthritis (RA)-associated interstitial lung disease (ILD) is common in patients with RA and leads to significant morbidity and mortality." | 3.30 | Treatment Outcomes for Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Real-World, Multisite Study of the Impact of Immunosuppression on Pulmonary Function Trajectory. ( Baqir, M; Boente, RD; Dai, J; Demoruelle, MK; Diaz, FJ; Donatelli, JM; Hamblin, MB; Iannazzo, NS; Kent, J; Lee, JS; Marll, M; Mathai, SK; Matson, SM; Moua, T; Pope, K; Ryu, JH; Walker, CM, 2023) |
| " Long-term therapy with infliximab, however, was associated with severe adverse events in two out of three SLE patients, which may have been provoked by infliximab and/or by their long-standing refractory SLE and previous therapies." | 2.74 | Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients. ( Aringer, M; Gordon, C; Graninger, WB; Houssiau, F; Rath, E; Smolen, JS; Steiner, G; Voll, RE, 2009) |
| "To review advances in the management of idiopathic inflammatory myopathy-associated interstitial lung disease (IIM-associated ILD) in the past 5 years, with highlights in myositis-specific antibody (MSA) groups." | 2.58 | Management of Interstitial Lung Disease in Patients With Myositis Specific Autoantibodies. ( Christopher-Stine, L; Mecoli, CA, 2018) |
| "Interstitial lung disease is commonly associated with the autoimmune inflammatory myopathies dermatomyositis and polymyositis and accounts for significant morbidity and mortality in these conditions." | 2.46 | Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? ( Christopher-Stine, L; Connors, GR; Danoff, SK; Oddis, CV, 2010) |
| "The clinical features of ASS include interstitial lung disease (ILD), myositis, arthritis, Raynaud's phenomenon, mechanic's hands, and unexplained fever." | 1.72 | A 25-Year-Old Saudi Woman with a 2-Year History of Antisynthetase Syndrome with Interstitial Lung Disease Who Commenced Azathioprine Treatment in the Third Trimester of Pregnancy and Had a Successful Birth at Term. ( Alshwairikh, LA; Babay, Z, 2022) |
| "Granulomatous and lymphocytic interstitial lung disease (GLILD) is a life-threatening complication in patients with common variable immunodeficiency (CVID), but the optimal treatment is unknown." | 1.62 | Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency. ( Barbeau, J; Baruah, D; Bausch-Jurken, M; Busalacchi, A; Chen, S; Cool, CD; Feng, M; Hammelev, E; Hintermeyer, MK; Rao, N; Routes, JM; Rymaszewski, A; Simpson, PM; Sosa-Lozano, LA; Verbsky, JW; Woodliff, J, 2021) |
| "Extended diagnostic measures revealed interstitial lung disease (ILD), polyserositis, polyarthritis and myopathy." | 1.51 | [Progressive respiratory failure and weakness in a 61-year-old woman]. ( Mahmud, M; Schnoor, U; Steinmetz, OM, 2019) |
| "A muscle biopsy was consistent with inflammatory myopathy." | 1.51 | Antisynthetase syndrome presenting as interstitial lung disease: a case report. ( Badshah, A; Haider, I; Humayun, M; Pervez, S, 2019) |
| "A 66-year-old woman with a history of interstitial lung disease presented with a 3-month history of dropped head syndrome (DHS), followed by camptocormia and extremity weakness." | 1.48 | Dropped Head Syndrome and the Presence of Rimmed Vacuoles in a Muscle Biopsy in Scleroderma-polymyositis Overlap Syndrome Associated with Anti-Ku Antibody. ( Higuchi, I; Jonosono, M; Mitsuyo, K; Yoshida, M; Yoshida, T, 2018) |
| "Interstitial lung disease is one of the most serious pulmonary complications, and the early diagnosis is essential to initiate a prompt therapy." | 1.43 | Pulmonary Langerhans Histiocytosis: an uncommon cause of interstitial pneumonia in a patient with Sjögren syndrome. ( Callejas Rubio, JL; González García, A; Ortego Centeno, N; Ríos Fernández, R, 2016) |
| "Azathioprine is a commonly prescribed therapy for connective tissue disease-associated interstitial lung disease (CTD-ILD)." | 1.43 | Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung disease. ( Adegunsoye, A; Chen, L; Chung, JH; Hsu, S; Lee, C; Montner, S; Noth, I; Oldham, JM; Strek, ME; Valenzi, E; Vij, R; Witt, LJ, 2016) |
| "Subgroup of idiopathic inflammatory myopathies, the antisynthetase syndrome is a rare chronic autoimmune disease, which is characterised by the presence of antibodies directed against aminoacyl-t-RNA-synthetases (family of intracytoplasmic enzymes with a vital role in the protein synthesis)." | 1.42 | Interstitial lung disease as first clinical manifestation within the antisynthetase syndrome--dermatomyositis. ( Mlădinescu, OF; Oancea, C; Trăilă, D; Tudorache, V, 2015) |
| "Interstitial lung disease is a rare but recognised complication of rituximab but has been rarely reported in the setting of ITP." | 1.38 | Rituximab-induced interstitial lung disease in a patient with immune thrombocytopenia purpura. ( Berkahn, L; Child, N; O'Carroll, M, 2012) |
| "Acute interstitial pneumonitis is the main pulmonary side effect during MTX treatment." | 1.35 | [Pneumonitis associated to methotrexate]. ( Marquina Barcos, A; Monón Ballarín, S; Mozota Duarte, J; Ruiz-Ruiz, FJ; Sáenz Abad, D, 2008) |
| "Azathioprine therapy was discontinued as a potential source of the pulmonary infiltrate." | 1.34 | A case of interstitial pneumonitis in a patient with ulcerative colitis treated with azathioprine. ( Kiss, I; Lonovics, J; Makula, E; Milassin, P; Molnar, T; Nagy, F; Tiszlavicz, L; Zollei, E, 2007) |
| "The azathioprine therapy was discontinued as the potential source of the pulmonary infiltrate." | 1.33 | [Azathioprine-associated interstitial pneumonitis]. ( Kiss, I; Lonovics, J; Makula, E; Milassin, P; Molnár, T; Nagy, F; Tiszlavicz, L; Zöllei, E, 2006) |
| "Sirolimus is an immunosuppressive drug which has proved its effectivity to reduce the incidence of acute rejection in renal transplantation receptors." | 1.32 | [Interstitial pneumonitis associated with sirolimus administration in a renal transplantation patient: a clinical case]. ( Gentil, MA; González Roncero, FM; López, M; Martínez, M; Mateos, J; Pereira, P; Rodríguez Algarra, G; Toro, J; Valdivia, MA, 2004) |
| "Retreatment with prednisolone and azathioprine has resulted in its improvement." | 1.31 | [Interstitial pneumonia associated with chronic thyroiditis]. ( Hashizume, T; Matsushita, K; Numata, H, 2002) |
| "We report a patient with microscopic polyarteritis nodosa (mPN) and interstitial pneumonia, who was subjected to investigation by bronchoalveolar lavage (BAL), thoracic computerized tomography (CT) and gallium-67 citrate (67Ga) scintigraphy before and after administration of glucocorticoid and immunosuppressive agents." | 1.30 | A case of microscopic polyarteritis nodosa with interstitial pneumonia successfully treated with steroid pulse therapy and immunosuppressive agents. ( Fujishima, M; Fujiwara, M; Hatama, S; Kumagai, H, 1998) |
| "Pulmonary involvement in mixed connective tissue disease has been considered to be relatively benign and easily treated with corticosteroids." | 1.29 | [Interstitial pneumonia associated with mixed connective tissue disease--marked improvement with azathioprine]. ( Aoki, S; Iwase, A; Kitamura, S; Matsuoka, R; Nagayama, T; Sakamoto, K; Shimizu, K; Suzuki, M, 1996) |
| "We conclude that the frequency of interstitial lung disease is high in Sjögren's syndrome and that an azathioprine-based treatment can favorably change the outcome in this population." | 1.29 | Interstitial lung disease in primary Sjögren's syndrome. Clinical-pathological evaluation and response to treatment. ( Barbas Filho, JV; Capelozzi, VL; de Carvalho, CR; Deheinzelin, D; Kairalla, RA; Saldiva, PH, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (16.05) | 18.2507 |
| 2000's | 23 (28.40) | 29.6817 |
| 2010's | 31 (38.27) | 24.3611 |
| 2020's | 14 (17.28) | 2.80 |
| Authors | Studies |
|---|---|
| Wong, AW | 2 |
| Khor, YH | 2 |
| Donohoe, K | 1 |
| Comes, A | 1 |
| Marcoux, V | 1 |
| Fisher, JH | 1 |
| Johannson, KA | 2 |
| Assayag, D | 1 |
| Morisset, J | 1 |
| Shapera, S | 1 |
| Khalil, N | 1 |
| Fell, CD | 1 |
| Manganas, H | 1 |
| Cox, G | 1 |
| To, T | 1 |
| Gershon, AS | 1 |
| Hambly, N | 1 |
| Halayko, AJ | 1 |
| Sadatsafavi, M | 1 |
| Wilcox, PG | 1 |
| Kolb, M | 1 |
| Richeldi, L | 1 |
| Ryerson, CJ | 2 |
| Lok, SD | 1 |
| Alshwairikh, LA | 1 |
| Babay, Z | 1 |
| Matson, SM | 2 |
| Baqir, M | 2 |
| Moua, T | 2 |
| Marll, M | 2 |
| Kent, J | 2 |
| Iannazzo, NS | 2 |
| Boente, RD | 2 |
| Donatelli, JM | 2 |
| Dai, J | 2 |
| Diaz, FJ | 2 |
| Demoruelle, MK | 2 |
| Hamblin, MB | 2 |
| Mathai, SK | 2 |
| Ryu, JH | 2 |
| Pope, K | 2 |
| Walker, CM | 2 |
| Lee, JS | 2 |
| Zhang, D | 1 |
| Adegunsoye, A | 2 |
| Oldham, JM | 2 |
| Kozlitina, J | 1 |
| Garcia, N | 1 |
| Poonawalla, M | 1 |
| Strykowski, R | 1 |
| Linderholm, AL | 1 |
| Ley, B | 1 |
| Ma, SF | 1 |
| Noth, I | 2 |
| Strek, ME | 2 |
| Wolters, PJ | 1 |
| Garcia, CK | 1 |
| Newton, CA | 1 |
| Gao, R | 1 |
| Pu, J | 1 |
| Wang, Y | 1 |
| Wu, Z | 1 |
| Liang, Y | 1 |
| Song, J | 1 |
| Pan, S | 1 |
| Han, F | 1 |
| Yang, L | 1 |
| Xu, X | 1 |
| Tang, J | 1 |
| Wang, X | 1 |
| Ibraheim, MK | 1 |
| Govindu, RR | 1 |
| Verbsky, JW | 2 |
| Hintermeyer, MK | 2 |
| Simpson, PM | 2 |
| Feng, M | 1 |
| Barbeau, J | 1 |
| Rao, N | 1 |
| Cool, CD | 1 |
| Sosa-Lozano, LA | 1 |
| Baruah, D | 1 |
| Hammelev, E | 1 |
| Busalacchi, A | 1 |
| Rymaszewski, A | 1 |
| Woodliff, J | 1 |
| Chen, S | 1 |
| Bausch-Jurken, M | 1 |
| Routes, JM | 2 |
| Tzilas, V | 1 |
| Kahn, N | 1 |
| Bouros, D | 1 |
| Amlani, B | 1 |
| Elsayed, G | 1 |
| Barvalia, U | 1 |
| Kanne, JP | 1 |
| Meyer, KC | 1 |
| Sandbo, N | 1 |
| Li, Z | 1 |
| McCoy, SS | 1 |
| Taha, N | 1 |
| Hosein, K | 1 |
| Grant-Orser, A | 1 |
| Lin-Shaw, A | 1 |
| Mura, M | 1 |
| Rasheed, N | 1 |
| Ahuja, R | 1 |
| Borneo, H | 1 |
| Kiboshi, T | 1 |
| Kotani, T | 2 |
| Konma, J | 1 |
| Makino, H | 1 |
| Matsuda, S | 1 |
| Suzuka, T | 1 |
| Wada, Y | 1 |
| Shiba, H | 1 |
| Hata, K | 1 |
| Shoda, T | 1 |
| Takeuchi, T | 2 |
| Moctezuma, SI | 1 |
| Panizo, CM | 1 |
| Landecho, MF | 1 |
| Yoshida, T | 2 |
| Yoshida, M | 1 |
| Mitsuyo, K | 1 |
| Jonosono, M | 1 |
| Higuchi, I | 1 |
| Gorospe, L | 1 |
| de la Puente-Bujidos, C | 1 |
| García-Gómez-Muriel, I | 1 |
| Barbolla-Díaz, I | 1 |
| Fernández-Méndez, MÁ | 1 |
| Mecoli, CA | 1 |
| Christopher-Stine, L | 3 |
| Mahmud, M | 1 |
| Schnoor, U | 1 |
| Steinmetz, OM | 1 |
| Palawisuth, S | 1 |
| Kantikosum, K | 1 |
| Patiyasikunt, M | 1 |
| Sriprasart, T | 1 |
| Asawanonda, P | 1 |
| Rerknimitr, P | 1 |
| Ron, R | 1 |
| Ruz-Caracuel, I | 1 |
| García, E | 1 |
| Montes-Ramírez, ML | 1 |
| Huapaya, JA | 1 |
| Silhan, L | 1 |
| Pinal-Fernandez, I | 1 |
| Casal-Dominguez, M | 1 |
| Johnson, C | 1 |
| Albayda, J | 1 |
| Paik, JJ | 1 |
| Sanyal, A | 1 |
| Mammen, AL | 1 |
| Danoff, SK | 2 |
| Zheng, JN | 1 |
| Yang, QR | 1 |
| Zhu, GQ | 1 |
| Pan, L | 1 |
| Xia, JX | 1 |
| Wang, Q | 1 |
| Badshah, A | 1 |
| Haider, I | 1 |
| Pervez, S | 1 |
| Humayun, M | 1 |
| Mira-Avendano, IC | 1 |
| Parambil, JG | 1 |
| Yadav, R | 1 |
| Arrossi, V | 1 |
| Xu, M | 1 |
| Chapman, JT | 1 |
| Culver, DA | 1 |
| Bozkirli, DE | 1 |
| Kozanoglu, I | 1 |
| Bozkirli, E | 1 |
| Yucel, E | 1 |
| Poormoghim, H | 1 |
| Rezaei, N | 1 |
| Sheidaie, Z | 1 |
| Almasi, AR | 1 |
| Moradi-Lakeh, M | 1 |
| Almasi, S | 1 |
| Andalib, E | 1 |
| Iudici, M | 1 |
| Cuomo, G | 1 |
| Vettori, S | 1 |
| Bocchino, M | 1 |
| Sanduzzi Zamparelli, A | 1 |
| Cappabianca, S | 1 |
| Valentini, G | 1 |
| González García, A | 1 |
| Callejas Rubio, JL | 1 |
| Ríos Fernández, R | 1 |
| Ortego Centeno, N | 1 |
| Gupta, R | 1 |
| Espiritu, J | 1 |
| Trăilă, D | 1 |
| Mlădinescu, OF | 1 |
| Oancea, C | 1 |
| Tudorache, V | 1 |
| Muñoz Gómez, MM | 1 |
| Montané, E | 1 |
| Arellano, AL | 1 |
| Olivé, A | 1 |
| Pathria, M | 1 |
| Urbine, D | 1 |
| Zumberg, MS | 1 |
| Guarderas, J | 1 |
| Steele, CL | 1 |
| Doré, M | 1 |
| Ammann, S | 1 |
| Loughrey, M | 1 |
| Montero, A | 1 |
| Burns, SO | 1 |
| Morris, EC | 1 |
| Gaspar, B | 1 |
| Gilmour, K | 1 |
| Bibi, S | 1 |
| Shendi, H | 1 |
| Devlin, L | 1 |
| Speckmann, C | 1 |
| Edgar, DM | 1 |
| Lee, C | 1 |
| Valenzi, E | 1 |
| Witt, LJ | 1 |
| Hsu, S | 1 |
| Chen, L | 1 |
| Montner, S | 1 |
| Chung, JH | 1 |
| Vij, R | 1 |
| Polosa, R | 1 |
| Di Mauro, C | 1 |
| Spampinato, B | 1 |
| Castelli, L | 1 |
| D'Amico, G | 1 |
| Edwards, CJ | 1 |
| Russo, C | 1 |
| Taki, H | 1 |
| Kawagishi, Y | 1 |
| Shinoda, K | 1 |
| Hounoki, H | 1 |
| Ogawa, R | 1 |
| Sugiyama, E | 1 |
| Tobe, K | 1 |
| Hernández Pérez, JM | 1 |
| Acosta Fernández, O | 1 |
| Aringer, M | 1 |
| Houssiau, F | 1 |
| Gordon, C | 1 |
| Graninger, WB | 1 |
| Voll, RE | 1 |
| Rath, E | 1 |
| Steiner, G | 1 |
| Smolen, JS | 1 |
| Bussone, G | 1 |
| Mouthon, L | 2 |
| Woischnik, M | 2 |
| Sparr, C | 2 |
| Kern, S | 2 |
| Thurm, T | 2 |
| Hector, A | 2 |
| Hartl, D | 2 |
| Liebisch, G | 2 |
| Mulugeta, S | 1 |
| Beers, MF | 1 |
| Schmitz, G | 2 |
| Griese, M | 2 |
| Connors, GR | 1 |
| Oddis, CV | 1 |
| Suto, M | 1 |
| Nagai, Y | 1 |
| Hasegawa, M | 1 |
| Handa, H | 1 |
| Ishikawa, O | 1 |
| Wuyts, WA | 1 |
| Thomeer, M | 1 |
| Demedts, MG | 1 |
| Patel, HC | 1 |
| Lauder, NN | 1 |
| Yu, KH | 1 |
| Wu, YJ | 1 |
| Kuo, CF | 1 |
| See, LC | 1 |
| Shen, YM | 1 |
| Chang, HC | 1 |
| Luo, SF | 1 |
| Ho, HH | 1 |
| Chen, IJ | 1 |
| Child, N | 1 |
| O'Carroll, M | 1 |
| Berkahn, L | 1 |
| Zarbock, R | 1 |
| Kaltenborn, E | 1 |
| Ishida, T | 1 |
| Makino, S | 1 |
| Chase, NM | 1 |
| Waukau, JK | 1 |
| Tomita-Mitchell, A | 1 |
| Casper, JT | 1 |
| Singh, S | 1 |
| Shahir, KS | 1 |
| Tisol, WB | 1 |
| Nugent, ML | 1 |
| Rao, RN | 1 |
| Mackinnon, AC | 1 |
| Goodman, LR | 1 |
| Mok, CC | 1 |
| To, CH | 1 |
| Szeto, ML | 1 |
| Sharma, S | 1 |
| Field, SK | 1 |
| Martínez, M | 1 |
| González Roncero, FM | 1 |
| López, M | 1 |
| Toro, J | 1 |
| Valdivia, MA | 1 |
| Pereira, P | 1 |
| Gentil, MA | 1 |
| Rodríguez Algarra, G | 1 |
| Mateos, J | 1 |
| Dheda, K | 1 |
| Lalloo, UG | 1 |
| Cassim, B | 1 |
| Mody, GM | 1 |
| Kaşifoğlu, T | 1 |
| Korkmaz, C | 1 |
| Ozkan, R | 1 |
| Nathan, SD | 1 |
| Sugimoto, T | 1 |
| Kanasaki, K | 1 |
| Koyama, T | 1 |
| Yokomaku, Y | 1 |
| Yasuda, H | 1 |
| Kashiwagi, A | 1 |
| Koya, D | 1 |
| Nagy, F | 2 |
| Molnár, T | 2 |
| Makula, E | 2 |
| Kiss, I | 2 |
| Milassin, P | 2 |
| Zöllei, E | 2 |
| Tiszlavicz, L | 2 |
| Lonovics, J | 2 |
| Cottin, V | 1 |
| Muñoz, A | 1 |
| Aranda, I | 1 |
| Pascual, J | 1 |
| Ferrando, C | 1 |
| Bakker, JA | 1 |
| Bierau, J | 1 |
| Drent, M | 1 |
| Sáenz Abad, D | 1 |
| Ruiz-Ruiz, FJ | 1 |
| Monón Ballarín, S | 1 |
| Mozota Duarte, J | 1 |
| Marquina Barcos, A | 1 |
| Bérezné, A | 1 |
| Ranque, B | 1 |
| Valeyre, D | 1 |
| Brauner, M | 1 |
| Allanore, Y | 1 |
| Launay, D | 1 |
| Le Guern, V | 1 |
| Kahn, JE | 1 |
| Couderc, LJ | 1 |
| Constans, J | 1 |
| Cohen, P | 1 |
| Mahr, A | 1 |
| Pagnoux, C | 1 |
| Hachulla, E | 1 |
| Kahan, A | 1 |
| Cabane, J | 1 |
| Guillevin, L | 1 |
| Pillans, PI | 1 |
| Tooke, AF | 1 |
| Bateman, ED | 1 |
| Ainslie, GM | 1 |
| Hizawa, N | 1 |
| Kojima, J | 1 |
| Kojima, T | 1 |
| Sukoh, N | 1 |
| Yamaguchi, E | 1 |
| Kawakami, Y | 1 |
| Matsushima, T | 1 |
| McCune, WJ | 1 |
| Vallance, DK | 1 |
| Lynch, JP | 1 |
| Suzuki, M | 1 |
| Shimizu, K | 1 |
| Sakamoto, K | 1 |
| Iwase, A | 1 |
| Aoki, S | 1 |
| Matsuoka, R | 1 |
| Nagayama, T | 1 |
| Kitamura, S | 1 |
| Deheinzelin, D | 1 |
| Capelozzi, VL | 1 |
| Kairalla, RA | 1 |
| Barbas Filho, JV | 1 |
| Saldiva, PH | 1 |
| de Carvalho, CR | 1 |
| Sacco, O | 1 |
| Fregonese, B | 1 |
| Picco, P | 1 |
| Faraci, M | 1 |
| Facchetti, P | 1 |
| Pistoia, V | 1 |
| Rossi, GA | 1 |
| Hirata, Y | 1 |
| Takizawa, H | 1 |
| Okazaki, H | 1 |
| Yoshida, A | 1 |
| Ishii, A | 1 |
| Kohno, T | 1 |
| Nakajima, J | 1 |
| Oka, T | 1 |
| Ito, K | 1 |
| Mori, H | 1 |
| Yamada, H | 1 |
| Terashi, K | 1 |
| Kohyama, T | 1 |
| Kawamata, N | 1 |
| Yamaguchi, A | 1 |
| Arima, N | 1 |
| Tanaka, H | 1 |
| Sauty, A | 1 |
| Rochat, T | 1 |
| Schoch, OD | 1 |
| Hamacher, J | 1 |
| Kurt, AM | 1 |
| Dayer, JM | 1 |
| Nicod, LP | 1 |
| Strobel, ES | 1 |
| Bonnet, RB | 1 |
| Werner, P | 1 |
| Schaefer, HE | 1 |
| Peter, HH | 1 |
| Hatama, S | 1 |
| Kumagai, H | 1 |
| Fujiwara, M | 1 |
| Fujishima, M | 1 |
| Cheema, GS | 1 |
| Quismorio, FP | 1 |
| Koga, H | 1 |
| Saitoh, F | 1 |
| Sakamoto, M | 1 |
| Harada, M | 1 |
| Yoshida, H | 1 |
| Sakisaka, S | 1 |
| Sata, M | 1 |
| Perreaux, F | 1 |
| Zenaty, D | 1 |
| Capron, F | 1 |
| Trioche, P | 1 |
| Odièvre, M | 1 |
| Labrune, P | 1 |
| Mimura, T | 1 |
| Kanda, H | 1 |
| Kubo, K | 1 |
| Hellmich, B | 1 |
| Schnabel, A | 1 |
| Bauer, T | 1 |
| Schatz, H | 1 |
| Hashizume, T | 1 |
| Numata, H | 1 |
| Matsushita, K | 1 |
11 reviews available for azathioprine and Diffuse Parenchymal Lung Disease
| Article | Year |
|---|---|
Management of Interstitial Lung Disease in Patients With Myositis Specific Autoantibodies.
Topics: Autoantibodies; Autoimmune Diseases; Azathioprine; Calcineurin Inhibitors; Humans; Immunosuppressive | 2018 |
Management of granulomatous lymphocytic interstitial lung disease in a patient with common variable immune deficiency.
Topics: Azathioprine; Common Variable Immunodeficiency; Cough; Dyspnea; Female; Humans; Immunoglobulins, Int | 2016 |
Interstitial lung disease in systemic sclerosis.
Topics: Antibodies, Monoclonal, Murine-Derived; Autoantibodies; Azathioprine; Contraindications; Cyclophosph | 2011 |
Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?
Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Biomarkers; B | 2010 |
Newer modes of treating interstitial lung disease.
Topics: Acetylcysteine; Adrenal Cortex Hormones; Azathioprine; Humans; Lung Diseases, Interstitial; Lung Tra | 2011 |
Therapeutic intervention: assessing the role of the international consensus guidelines.
Topics: Animals; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Glucocorticoids; Humans; Immunos | 2005 |
[Idiopathic interstitial pneumonia: treatment].
Topics: Acetylcysteine; Acute Disease; Adrenal Cortex Hormones; Adult; Age Factors; Aged; Azathioprine; Benz | 2006 |
Acute polyarthritis associated with azathioprine for interstitial lung disease.
Topics: Acute Disease; Arthritis; Azathioprine; Drug Hypersensitivity; Drug Therapy, Combination; Female; Hu | 1995 |
Immunosuppressive drug therapy.
Topics: Adrenal Cortex Hormones; Azathioprine; Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Cyc | 1994 |
Pulmonary involvement in adult-onset Still's disease.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Chronic Disease; Cyclophosphamide; Humans; Immunoglobu | 1999 |
[Treatment of steroid-resistant polymyositis and dermatomyositis].
Topics: Animals; Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Cyclosporine; Dermatomyositis; Dr | 2001 |
4 trials available for azathioprine and Diffuse Parenchymal Lung Disease
66 other studies available for azathioprine and Diffuse Parenchymal Lung Disease
| Article | Year |
|---|---|
Prescribing Patterns and Tolerability of Mycophenolate and Azathioprine in Patients with Nonidiopathic Pulmonary Fibrosis Fibrotic Interstitial Lung Disease.
Topics: Azathioprine; Fibrosis; Humans; Idiopathic Pulmonary Fibrosis; Immunosuppressive Agents; Lung Diseas | 2022 |
Malignancy Risk Associated With Mycophenolate Mofetil or Azathioprine in Patients With Fibrotic Interstitial Lung Disease.
Topics: Azathioprine; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Mycophenolic Acid; Neop | 2022 |
A 25-Year-Old Saudi Woman with a 2-Year History of Antisynthetase Syndrome with Interstitial Lung Disease Who Commenced Azathioprine Treatment in the Third Trimester of Pregnancy and Had a Successful Birth at Term.
Topics: Adult; Autoantibodies; Autoimmune Diseases; Azathioprine; Female; Humans; Lung Diseases, Interstitia | 2022 |
Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease.
Topics: Azathioprine; Connective Tissue Diseases; Humans; Idiopathic Pulmonary Fibrosis; Immunosuppression T | 2023 |
Rheumatoid Arthritis-Associated Interstitial Lung Disease.
Topics: Arthritis, Rheumatoid; Azathioprine; Dyspnea; Hand; Humans; Lung; Lung Diseases, Interstitial; Male; | 2020 |
Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency.
Topics: Adolescent; Adult; Azathioprine; Common Variable Immunodeficiency; Enzyme Inhibitors; Female; Humans | 2021 |
Azathioprine for Connective Tissue Disease-Associated Interstitial Lung Disease: In Search for Evidence-Based Medicine.
Topics: Azathioprine; Connective Tissue Diseases; Evidence-Based Medicine; Humans; Lung Diseases, Interstiti | 2020 |
Treatment of primary sjögren's syndrome-related interstitial lung disease: a retrospective cohort study.
Topics: Aged; Aged, 80 and over; Azathioprine; Electronic Health Records; Female; Humans; Immunosuppressive | 2020 |
TPMT and HLA-DQA1-HLA-DRB genetic profiling to guide the use of azathioprine in the treatment of interstitial lung disease: First experience.
Topics: Azathioprine; HLA-DQ alpha-Chains; Humans; Lung Diseases, Interstitial; Methyltransferases | 2021 |
Polyangiitis overlap syndrome: a novel presentation of microscopic polyangiitis and eosinophilic granulomatosis with polyangiitis.
Topics: Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Churg-Strauss Syndrome; Cyclophosphamide; Fema | 2021 |
Comparison of therapeutic effects of combination therapy with prednisolone and tacrolimus or azathioprine on progressive interstitial pneumonia with systemic sclerosis.
Topics: Azathioprine; Drug Therapy, Combination; Fibrosis; Humans; Immunosuppressive Agents; Lung Diseases, | 2022 |
Common variable immunodeficiency-associated granulomatous and lymphocytic interstitial lung disease successfully treated with a combination regimen of rituximab and azathioprine.
Topics: Azathioprine; Common Variable Immunodeficiency; Drug Therapy, Combination; Female; Humans; Immunosup | 2017 |
Dropped Head Syndrome and the Presence of Rimmed Vacuoles in a Muscle Biopsy in Scleroderma-polymyositis Overlap Syndrome Associated with Anti-Ku Antibody.
Topics: Aged; Anti-Inflammatory Agents; Autoantibodies; Azathioprine; Female; Head Movements; Humans; Immuno | 2018 |
Asymmetric Calcinosis in an Adult Patient With Antisynthetase Syndrome.
Topics: Amino Acyl-tRNA Synthetases; Autoantibodies; Azathioprine; Calcinosis; Female; Humans; Immunosuppres | 2019 |
[Progressive respiratory failure and weakness in a 61-year-old woman].
Topics: Amino Acyl-tRNA Synthetases; Antibodies, Antinuclear; Autoantibodies; Azathioprine; Combined Modalit | 2019 |
A Bad Sign: Dermatomyositis with Interstitial Lung Disease.
Topics: Anti-Inflammatory Agents; Azathioprine; Dermatomyositis; Dexamethasone; Fatal Outcome; Humans; Immun | 2019 |
IgG4-related disease in a patient with HIV infection.
Topics: Azathioprine; Dyspnea; Glucocorticoids; HIV Infections; Humans; Immunoglobulin G; Immunoglobulin G4- | 2019 |
Long-Term Treatment With Azathioprine and Mycophenolate Mofetil for Myositis-Related Interstitial Lung Disease.
Topics: Azathioprine; Enzyme Inhibitors; Female; Follow-Up Studies; Forced Expiratory Volume; Glucocorticoid | 2019 |
Comparative efficacy and safety of immunosuppressive therapies for systemic sclerosis related interstitial lung disease: A Bayesian network analysis.
Topics: Adult; Azathioprine; Bayes Theorem; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Lung | 2020 |
Antisynthetase syndrome presenting as interstitial lung disease: a case report.
Topics: Adult; Antibodies, Antinuclear; Autoantibodies; Azathioprine; Creatine Kinase; Diagnosis, Differenti | 2019 |
A retrospective review of clinical features and treatment outcomes in steroid-resistant interstitial lung disease from polymyositis/dermatomyositis.
Topics: Adult; Azathioprine; Cyclophosphamide; Dermatomyositis; Drug Administration Schedule; Drug Resistanc | 2013 |
Antisynthetase syndrome with refractory lung involvement and myositis successfully treated with double filtration plasmapheresis.
Topics: Aged; Autoantibodies; Azathioprine; Combined Modality Therapy; Creatine Kinase; Cyclophosphamide; Em | 2013 |
Systemic sclerosis: comparison of efficacy of oral cyclophosphamide and azathioprine on skin score and pulmonary involvement-a retrospective study.
Topics: Administration, Oral; Adult; Aged; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Female | 2014 |
Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic sclerosis (SSc-ILD): efficacy of maintenance immunosuppression in responders and non-responders.
Topics: Adult; Azathioprine; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Therapy, Combination; | 2015 |
Pulmonary Langerhans Histiocytosis: an uncommon cause of interstitial pneumonia in a patient with Sjögren syndrome.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Azathioprine; Female; Histiocytosis, Langerhans-Cell; Humans; | 2016 |
Azathioprine for the Rare Case of Nonspecific Interstitial Pneumonitis in a Patient with Psoriasis.
Topics: Adult; Azathioprine; Biopsy; Bronchoscopy; Female; Humans; Immunosuppressive Agents; Lung Diseases, | 2015 |
Interstitial lung disease as first clinical manifestation within the antisynthetase syndrome--dermatomyositis.
Topics: Adult; Antibodies, Antinuclear; Autoantibodies; Azathioprine; Biomarkers; Dermatomyositis; Disease P | 2015 |
[Tacrolimus-induced gynecomastia in a patient with polymyositis].
Topics: Azathioprine; Drug Substitution; Drug Therapy, Combination; Gynecomastia; Humans; Immunosuppressive | 2016 |
X-linked Inhibitor of Apoptosis Complicated by Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) and Granulomatous Hepatitis.
Topics: Azathioprine; Biomarkers; Biopsy; Bone Marrow; Child, Preschool; Female; Genetic Diseases, X-Linked; | 2016 |
Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung disease.
Topics: Adult; Aged; Azathioprine; Connective Tissue Diseases; Cross-Over Studies; Female; Hospitalization; | 2016 |
A patient with antihistidyl-tRNA synthetase positive polymyositis presenting as acute respiratory distress syndrome.
Topics: Antirheumatic Agents; Autoantibodies; Azathioprine; Female; Histidine-tRNA Ligase; Humans; Lung Dise | 2008 |
Interstitial pneumonitis associated with infliximab therapy without methotrexate treatment.
Topics: Aged; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Drug Therap | 2009 |
[Lung disease secondary to morphea en coup de sabre, a form of localized scleroderma].
Topics: Adrenal Cortex Hormones; Adult; Autoantibodies; Azathioprine; Drug Therapy, Combination; Facial Hemi | 2009 |
A non-BRICHOS surfactant protein c mutation disrupts epithelial cell function and intercellular signaling.
Topics: Amino Acid Substitution; Animals; Azathioprine; Bronchoalveolar Lavage Fluid; Calnexin; Calreticulin | 2010 |
Azathioprine-induced pure red cell aplasia in a systemic sclerosis patient with interstitial pneumonia.
Topics: Adult; Azathioprine; Female; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Red-Cell | 2011 |
The antisynthetase syndrome.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antinuclear; Azathioprine; Cryptogenic Organizing Pneum | 2011 |
Survival analysis of patients with dermatomyositis and polymyositis: analysis of 192 Chinese cases.
Topics: Adult; Aged; Antirheumatic Agents; Azathioprine; Dermatomyositis; Diabetes Complications; Female; Fo | 2011 |
Rituximab-induced interstitial lung disease in a patient with immune thrombocytopenia purpura.
Topics: Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Combined Modality Therapy; | 2012 |
The surfactant protein C mutation A116D alters cellular processing, stress tolerance, surfactant lipid composition, and immune cell activation.
Topics: Animals; Azathioprine; Cell Line; Cyclophosphamide; Epithelial Cells; Gene Expression; Humans; Hydro | 2012 |
Pulmonary toxicity after initiation of azathioprine for treatment of interstitial pneumonia in a patient with rheumatoid arthritis.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Dyspnea; Humans; Lung Diseases, Int | 2012 |
Successful treatment of dermatomyositis-related rapidly progressive interstitial pneumonitis with sequential oral cyclophosphamide and azathioprine.
Topics: Administration, Oral; Antirheumatic Agents; Azathioprine; Cyclophosphamide; Dermatomyositis; Disease | 2003 |
Steroids and/or cytotoxic agents should be used early in the management of patients with IPF--the pro argument.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic A | 2004 |
Steroids and/or cytotoxic agents should be used early in the management of patients with IPF - the con argument.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic A | 2004 |
[Interstitial pneumonitis associated with sirolimus administration in a renal transplantation patient: a clinical case].
Topics: Aged; Antilymphocyte Serum; Azathioprine; Cyclosporine; Diagnosis, Differential; Diuretics; Doxazosi | 2004 |
Experience with azathioprine in systemic sclerosis associated with interstitial lung disease.
Topics: Azathioprine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyspnea; Female; Glucocor | 2004 |
Cytomegalovirus-induced interstitial pneumonitis in a patient with dermatomyositis.
Topics: Adult; Antiviral Agents; Azathioprine; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; De | 2006 |
A case of myeloperoxidase-antineutrophil cytoplasmic antibody positive-polyarteritis nodosa complicated by interstitial pneumonia and rapidly progressive renal failure.
Topics: Aged; Angiography; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Azathioprine; F | 2007 |
[Azathioprine-associated interstitial pneumonitis].
Topics: Adult; Azathioprine; Colitis, Ulcerative; Humans; Immunosuppressive Agents; Lung Diseases, Interstit | 2006 |
A case of interstitial pneumonitis in a patient with ulcerative colitis treated with azathioprine.
Topics: Adult; Azathioprine; Colitis, Ulcerative; Humans; Immunosuppressive Agents; Lung Diseases, Interstit | 2007 |
[Idiopathic bronchiolocentric interstitial pneumonia: a new idiopathic interstitial pneumonia].
Topics: Adult; Azathioprine; Biopsy; Diagnosis, Differential; Female; Humans; Immunosuppressive Agents; Lung | 2007 |
Therapeutic regimens in interstitial lung disease guided by genetic screening: fact or fiction?
Topics: Azathioprine; Genetic Testing; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Methyl | 2007 |
[Pneumonitis associated to methotrexate].
Topics: Adrenal Cortex Hormones; Azathioprine; Diagnosis, Differential; Female; Humans; Immunosuppressive Ag | 2008 |
Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicenter open-label study.
Topics: Administration, Oral; Adult; Antirheumatic Agents; Azathioprine; Cyclophosphamide; Drug Therapy, Com | 2008 |
A patient with chronic hepatitis C who simultaneously developed interstitial pneumonia, hemolytic anemia and cholestatic liver dysfunction after alpha-interferon administration.
Topics: Anemia, Hemolytic, Autoimmune; Azathioprine; Cholestasis, Intrahepatic; Female; Hepatitis C; Humans; | 1994 |
[Interstitial pneumonia associated with mixed connective tissue disease--marked improvement with azathioprine].
Topics: Azathioprine; Drug Administration Schedule; Humans; Immunosuppressive Agents; Lung Diseases, Interst | 1996 |
Interstitial lung disease in primary Sjögren's syndrome. Clinical-pathological evaluation and response to treatment.
Topics: Adult; Aged; Azathioprine; Bronchoalveolar Lavage Fluid; Female; Humans; Lung Diseases, Interstitial | 1996 |
Common variable immunodeficiency presenting in a girl as lung infiltrates and mediastinal adenopathies leading to severe "superior vena caval" syndrome.
Topics: Anti-Inflammatory Agents; Azathioprine; Child; Common Variable Immunodeficiency; Diagnosis, Differen | 1996 |
[Interstitial pneumonia with Sjögren's syndrome: successful treatment with steroids and an immunosuppressant].
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Drug Therapy, Combination; Dyspnea; Female; Humans; I | 1997 |
[Primary pulmonary non-Hodgkin's lymphoma in a patient with dermatomyositis].
Topics: Azathioprine; Dermatomyositis; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Lung N | 1997 |
Pulmonary fibrosis with predominant CD8 lymphocytic alveolitis and anti-Jo-1 antibodies.
Topics: Aged; Antibodies, Antinuclear; Autoantibodies; Azathioprine; Biopsy, Needle; Bronchoalveolar Lavage | 1997 |
Bronchiolitis obliterans organising pneumonia and primary biliary cirrhosis-like lung involvement in a patient with primary biliary cirrhosis.
Topics: Adrenal Cortex Hormones; Antimetabolites; Azathioprine; Biopsy, Needle; Bronchoalveolar Lavage; Cryp | 1998 |
A case of microscopic polyarteritis nodosa with interstitial pneumonia successfully treated with steroid pulse therapy and immunosuppressive agents.
Topics: Anti-Inflammatory Agents; Azathioprine; Bronchoalveolar Lavage; Cyclophosphamide; Drug Administratio | 1998 |
Pulse intravenous cyclophosphamide treatment for steroid-resistant interstitial pneumonitis associated with polymyositis.
Topics: Adult; Azathioprine; Biopsy; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosupp | 1999 |
Azathioprine-induced lung toxicity and efficacy of cyclosporin A in a young girl with type 2 autoimmune hepatitis.
Topics: Adolescent; Autoantibodies; Azathioprine; Cyclosporine; Female; Hepatitis, Autoimmune; Humans; Immun | 2000 |
[Interstitial pulmonary disease in systemic scleroderma: treatment].
Topics: Azathioprine; Cytokines; Glucocorticoids; Hematopoietic Stem Cell Transplantation; Humans; Immunosup | 2002 |
[Interstitial pneumonia associated with chronic thyroiditis].
Topics: Anti-Inflammatory Agents; Azathioprine; Chronic Disease; Drug Therapy, Combination; Female; Humans; | 2002 |